Pharming (PHAR) Exchange Rate Effect (2020 - 2025)
Pharming (PHAR) posted Exchange Rate Effect of $1.2 million for Q4 2025, down 81.2% on a QoQ basis from $6.6 million in Q3 2025, and up 155.93% year-over-year from $482548.2 in Q4 2024.
Pharming (PHAR) Exchange Rate Effect (2020 - 2025) Analysis & Trends
Pharming's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- Quarterly Exchange Rate Effect rose 155.93% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (up 365.04% YoY) and the FY2025 annual result came in at $7.9 million, up 458.11% from the prior year.
- Exchange Rate Effect was $1.2 million for Q4 2025 at Pharming, down from $6.6 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $6.6 million in Q3 2025 and bottomed at -$11.7 million in Q3 2022.
- A 5-year average of -$264544.4 and a median of $405000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect sank 4498.65% — and 2022, when it surged 162.31%.
- Pharming's Exchange Rate Effect stood at -$650000.0 in 2021, then jumped by 162.31% to $405000.0 in 2022, then increased by 8.4% to $439000.0 in 2023, then tumbled by 602.96% to -$2.2 million in 2024, then jumped by 155.93% to $1.2 million in 2025.
- Business Quant data shows PHAR's Exchange Rate Effect at $1.2 million in Q4 2025, $6.6 million in Q3 2025, and -$2.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 6.57 Mn |
| Sep 30, 2025 | 6.57 Mn |
| Dec 31, 2024 | -2.21 Mn |
| Dec 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | 439,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Sep 30, 2023 | -913,000.00 |
| Sep 30, 2023 | -913,000.00 |
| Dec 31, 2022 | 405,000.00 |
| Dec 31, 2022 | 405,000.00 |
| Sep 30, 2022 | -11.66 Mn |
| Sep 30, 2022 | -11.66 Mn |
| Dec 31, 2021 | -650,000.00 |
| Dec 31, 2021 | -650,000.00 |
| Sep 30, 2021 | 4.40 Mn |
| Sep 30, 2021 | 4.40 Mn |
| Dec 31, 2020 | -14,134.60 |
| Dec 31, 2020 | -14,134.60 |